[1]龙启来,郭剑明 综述,王国民 审校.高强度聚焦超声及放射性粒子近距离治疗在前列腺癌的应用[J].中国微创外科杂志,2011,11(3):264-267.
点击复制

高强度聚焦超声及放射性粒子近距离治疗在前列腺癌的应用()
分享到：

《中国微创外科杂志》[ISSN:1009-6604/CN:11-4526/R]

卷:
11
期数:
2011年3期
页码:
264-267
栏目:
文献综述
出版日期:
2011-03-20

文章信息/Info

作者:
龙启来; 郭剑明 综述; 王国民 审校
复旦大学附属中山医院泌尿外科，上海200032
分类号:
R737.25
文献标志码:
A

参考文献/References:

[1]Jemal A,Siegel R,Ward E,et al.Cancer statistics,2009.CA Cancer J Clin,2009,59(4):225-249.
[2]郑莹，吴春晓，金凡，等.上海市区1973-2005年癌症的发病趋势.诊断学理论与实践，2009，8(1):25-32.
[3]Gelet A,Chapelon JY,Bouvier R,et al.Treatment of prostate cancer with transrectal focused ultrasound:early clinical experience.Eur Urol,1996,29(2):174-183.
[4]Watkin NA,Ter Haar GR,Morris SB,et al.The urological applications of focused ultrasound surgery.Br J Urol,1995,75(supple):1-8.
[5]Zderic V,Keshavarzi A,Noble ML.Hemorrhage control in arteries using highintensity focused ultrasound:A survival study.Ultras,2006,44(1):46-53.
[6]Hu Z,Yang XY,Liu Y.Release of endogenous danger signals from HIFUtreated tumor cells and their stimulatory effects on APCs.Biochem Biophys Res Commun,2005,335(1):124-131.
[7]叶欣,费兴波.高强度聚焦超声治疗肝癌后免疫功能的变化.中国肿瘤临床与康复,2005,12(1):40-43.
[8]武睿毅,王国民,曾昭冲.高强度聚集超声治疗小鼠前列腺癌皮下移植瘤的疗效.复旦学报(医学版),2004,31(1):15-18.
[9]梅骅,陈凌武,高新,主编.泌尿外科手术学.北京：人民卫生出版社，2007.717-720.
[10]Ahmed HU,Zacharakis E,Dudderidge T,et al.Highintensityfocused ultrasound in the treatment of primary prostate cancer:the first UK series.Br J Cancer,2009,101(1):19-26.
[11]Uchida T,Ohkusa H,Nagata Y,et al.Treatment of localized prostate cancer using highintensity focused ultrasound.BJU Int,2006,97:56-61.
[12]Poissonnier L,Chapelon JY,Rouvière O,et al.Control of prostate cancer by transrectal HIFU in 227 patients.Eur Urol,2007,51:381-387.
[13]Vallancien G,Prapotnich D,Cathelineau X,et al.Transrectal focused ultrasound combined with transurethral resection of the prostate for the treatment of localized prostate cancer:feasibility study.J Urol,2004,171:2265-2267.
[14]Chaussy C,Thüroff S.The status of highintensity focused ultrasound in the treatment of localized prostate cancer and the impact of a combined resection.Curr Urol Rep,2003,4:248-252.
[15]Holm HH,Stroyer I,Hansen H,et al.Ultrasonically guided percutaneous interstitial implantation of iodine 125 seeds in cancer therapy.Br J Radiol，1981,54(644):665-670.
[16]Bladou F,Thuret R,Gravis G,et al.Techniques,indications and result s of permanent prostate brachyt herapy for localized prostate cancer.Ann Urol(Paris),2007,41(2):68-79.
[17]赵永斌，胡卫列，杨槐,等.高强度聚焦超声系统治疗局限性前列腺癌(附26例报告).中国男科学杂志,2008,22(11)：28-30.
[18]Chauveinc L,Flam T,Solignac S,et al.Indications for curitherapy of the prostate using permanent implants.Cancer Radiother,2002,6:154-158.
[19]Ragde H,Grado GL,Nadir BS.Brachytherapy for clinically localized prostate cancer:thirteenyear diseasefree survival of 769 consecutive prostate cancer patients treated with permanent implants alone.Arch Esp Urol,2001,54:739-747.
[20]Rivard MJ,Butler WM,Devlin PM,et al.American Brachytherapy Society recommends no change for prostate permanent implant dose prescriptions using iodine125 or palladium103.Brachytherapy,2007,6(1):34-37.
[21]Wallner K,Roy J,Harrion L.Dosimetry guidelines to minimize urethral and rectal morbidity following transperineal I125 prostate brachytherapy.Int J Radiat Oncol Biol Phys,1995,32(2):465-471.
[22]Merrick GS,Butler WM,Wallner KE,et al.Longterm urinary quality of life after permanent prostate brachytherapy.Int J Radiat Oncol Biol Phys,2003,56:454-461.
[23]王国民，徐志兵，朱延军，等.125I放射性粒子永久植入治疗前列腺癌.中华泌尿外科杂志,2005,26(4):263-266.
[24]黄毅，王俊杰，冉维强，等.前列腺癌125I放射粒子植入术后直肠并发症及防治.中国微创外科杂志，2007,7(2):125-126.
[25]Aileen BC，Anthony VD，Bridget AN，et al．Patient and treatment factors associated with complications after prostate brachytherapy．J Clin Oncol,2006,24:5298-5304.
[26]Potters L,Morgenstern C,Calugaru E,et al.12year outcomes following permament prostate brachytherapy in patients with clinically localized prostate cancer.J Urol，2005,173(5):1562-1566.
[27]Sylvester JE,Grimm PD,Blasko JC,et al.Fifteenyear biochemical relapse free survival in clinical stage T1-T3 prostate cancer following combined external beam radiotherapy and brachytherapy:Seattle experience.Int J Radiat Oncol Biol Phys,2007,67:57-64.
[28]Stone NN,Stock RG,Unger P.Intermediate term biochemicalfree progression and local control following 125 iodine brachytherapy for prostate cancer.J Urol，2005,173:803-807.
[29]Zelefsky MJ,Yamada Y,Cohen GN,et al.Fiveyear outcome of intraoperative conformal permanent I125 interstitial implantation for patients with clinically localized prostate cancer.Int J Radiat Oncol Biol Phys,2007,67:65-70.

更新日期/Last Update: 2013-04-18